Filter posts

On Track for a Record Breaking 2018 – #BIF18 Opening Plenary

Despite some recent market volatility, the industry is well positioned for long-term growth and success. …

How Companies are Using Microbiome-Based Therapies to Improve Patient Outcomes

On Wednesday morning at the BIO Investor Forum, leaders from six companies at the forefront …

Innovation Intersecting with Investing – Welcome to the BIO Investor Forum

Today marks the 17th opening of the BIO Investor Forum—a place where emerging biotech companies, …

Trump’s Drug Pricing Blueprint to be Explored at Upcoming Summit

In just a few short weeks, BIO will host its annual Patient and Health Advocacy …

Delivering Innovative Medicines to Patients

Over the past two years, I lost both my father and my brother to cancer. …

Investment Market Good for Deal-making at #BIF18

As we move into the final quarter of 2018, we reflect on a year with …

Digital Health Innovation to be Spotlighted at the BIO Investor Forum

Is your company trying to expand into “digiceuticals” or digital therapeutics? Are you looking to …

It Starts with One

Every year around this time, we begin the process of putting together our educational program …

Bull Market Bodes Well for #BIF18

The rapid pace of scientific discovery, FDA approvals, commercialization of medicines held long in pipelines, …

The Patient Perspective-Valuable for Drug Development

Congress, the Food and Drug Administration (FDA), drug developers, researchers and patient groups have all …